121 related articles for article (PubMed ID: 31704345)
1. In vivo antitumour properties of tribenzyltin carboxylates in a 4T1 murine metastatic mammary tumour model: Enhanced efficacy by PLGA nanoparticles.
Anasamy T; Chee CF; Kiew LV; Chung LY
Eur J Pharm Sci; 2020 Jan; 142():105140. PubMed ID: 31704345
[TBL] [Abstract][Full Text] [Related]
2. Biodegradable PLGA implants containing doxorubicin-loaded chitosan nanoparticles for treatment of breast tumor-bearing mice.
Kefayat A; Vaezifar S
Int J Biol Macromol; 2019 Sep; 136():48-56. PubMed ID: 31195043
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterisation and in vitro and in vivo evaluation of CD44-targeted chondroitin sulphate-conjugated doxorubicin PLGA nanoparticles.
Liu P; Chen N; Yan L; Gao F; Ji D; Zhang S; Zhang L; Li Y; Xiao Y
Carbohydr Polym; 2019 Jun; 213():17-26. PubMed ID: 30879657
[TBL] [Abstract][Full Text] [Related]
4. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
[TBL] [Abstract][Full Text] [Related]
5. Na
Araste F; Abnous K; Hashemi M; Dehshahri A; Detampel P; Alibolandi M; Ramezani M
Eur J Pharm Sci; 2020 Feb; 143():105207. PubMed ID: 31870814
[TBL] [Abstract][Full Text] [Related]
6. Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer.
Bharali DJ; Yalcin M; Davis PJ; Mousa SA
Nanomedicine (Lond); 2013 Dec; 8(12):1943-54. PubMed ID: 23448245
[TBL] [Abstract][Full Text] [Related]
7. E-Jet 3D-Printed Scaffolds as Sustained Multi-Drug Delivery Vehicles in Breast Cancer Therapy.
Qiao X; Yang Y; Huang R; Shi X; Chen H; Wang J; Chen Y; Tan Y; Tan Z
Pharm Res; 2019 Nov; 36(12):182. PubMed ID: 31741089
[TBL] [Abstract][Full Text] [Related]
8. Chitosan-Coated-PLGA Nanoparticles Enhance the Antitumor and Antimigration Activity of Stattic - A STAT3 Dimerization Blocker.
Fong SS; Foo YY; Saw WS; Leo BF; Teo YY; Chung I; Goh BT; Misran M; Imae T; Chang CC; Chung LY; Kiew LV
Int J Nanomedicine; 2022; 17():137-150. PubMed ID: 35046650
[TBL] [Abstract][Full Text] [Related]
9. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
[TBL] [Abstract][Full Text] [Related]
10. Chitosan-Coated Poly(lactic-co-glycolic acid)-Diiodinated boron-Dipyrromethene Nanoparticles Improve Tumor Selectivity and Stealth Properties in Photodynamic Cancer Therapy.
Voon SH; Tiew SX; Kue CS; Lee HB; Kiew LV; Misran M; Kamkaew A; Burgess K; Chung LY
J Biomed Nanotechnol; 2016 Jul; 12(7):1431-52. PubMed ID: 29336539
[TBL] [Abstract][Full Text] [Related]
11. Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced.
Song X; Wang J; Xu Y; Shao H; Gu J
Colloids Surf B Biointerfaces; 2019 Aug; 180():110-117. PubMed ID: 31030022
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronidase Embedded in Nanocarrier PEG Shell for Enhanced Tumor Penetration and Highly Efficient Antitumor Efficacy.
Zhou H; Fan Z; Deng J; Lemons PK; Arhontoulis DC; Bowne WB; Cheng H
Nano Lett; 2016 May; 16(5):3268-77. PubMed ID: 27057591
[TBL] [Abstract][Full Text] [Related]
13. Effects of surface modification of As
Song X; You J; Shao H; Yan C
Colloids Surf B Biointerfaces; 2018 Sep; 169():289-297. PubMed ID: 29793091
[TBL] [Abstract][Full Text] [Related]
14. Cabozantinib-Loaded PLGA Nanoparticles: A Potential Adjuvant Strategy for Surgically Resected High-Risk Non-Metastatic Renal Cell Carcinoma.
Lee HW; Seo HS; Yeom SY; Kim SN; Kim CR; Park DH; Park W; Choy YB; Park CG; Seo SI
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293494
[TBL] [Abstract][Full Text] [Related]
15. Poly-(Lactic-co-Glycolic) Acid Nanoparticles for Synergistic Delivery of Epirubicin and Paclitaxel to Human Lung Cancer Cells.
Sharma N; Kumari RM; Gupta N; Syed A; Bahkali AH; Nimesh S
Molecules; 2020 Sep; 25(18):. PubMed ID: 32947799
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
[TBL] [Abstract][Full Text] [Related]
17. A novel nanoformulation of PLGA with high non-ionic surfactant content improves in vitro and in vivo PTX activity against lung cancer.
Jiménez-López J; El-Hammadi MM; Ortiz R; Cayero-Otero MD; Cabeza L; Perazzoli G; Martin-Banderas L; Baeyens JM; Prados J; Melguizo C
Pharmacol Res; 2019 Mar; 141():451-465. PubMed ID: 30634051
[TBL] [Abstract][Full Text] [Related]
18. Novel doxorubicin / folate-targeted trans-ferulic acid-loaded PLGA nanoparticles combination: In-vivo superiority over standard chemotherapeutic regimen for breast cancer treatment.
Helmy SA; El-Mofty S; El Gayar AM; El-Sherbiny IM; El-Far YM
Biomed Pharmacother; 2022 Jan; 145():112376. PubMed ID: 34749055
[TBL] [Abstract][Full Text] [Related]
19. Dual-Modality Poly-l-histidine Nanoparticles to Deliver Peptide Nucleic Acids and Paclitaxel for In Vivo Cancer Therapy.
Wahane A; Malik S; Shih KC; Gaddam RR; Chen C; Liu Y; Nieh MP; Vikram A; Bahal R
ACS Appl Mater Interfaces; 2021 Sep; 13(38):45244-45258. PubMed ID: 34524806
[TBL] [Abstract][Full Text] [Related]
20. Enhanced Antitumor Efficacy of Curcumin-Loaded PLGA Nanoparticles Coated with Unique Fungal Hydrophobin.
Sun L; Xu H; Xu JH; Wang SN; Wang JW; Zhang HF; Jia WR; Li LS
AAPS PharmSciTech; 2020 Jun; 21(5):171. PubMed ID: 32529560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
